Replies to post #165 on ViroPharma Incorporated (VPHM)

[surf1944]

ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study
- New Data Validating VP20621 Clinical Proof of Concept Presented at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) -

http://finance.yahoo.com/news/ViroPharma-Announces-prnews-3079600362.html?x=0&.v=1